Trials / Completed
CompletedNCT02399592
Tocotrienol as a Nutritional Supplement in Patients With Advanced Ovarian Cancer
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 23 (actual)
- Sponsor
- Vejle Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to to investigate the effect of tocotrienol as a nutritional supplement in combination with bevacizumab in patients with advanced ovarian cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bevacizumab | 10 mg/kg q3w |
| DRUG | Tocotrinol | 300 mg tid |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2019-07-01
- Completion
- 2019-07-01
- First posted
- 2015-03-26
- Last updated
- 2020-11-30
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT02399592. Inclusion in this directory is not an endorsement.